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Focus groupBackground: Recent debates on the introduction of new childhood vaccines in the UK have suggested that
‘peace of mind’ (PoM) might influence decision making. The aim of this study is to ascertain the impor-
tance of ‘PoM’ in individuals’ decision making.
Methods: Four focus groups were conducted in the UK. Participants were 22 females and 2 males, aged
18–74 years, with a selection of non-parents, parents, guardians and foster carers. Data were analysed
using an inductive thematic framework approach and conceptualised using the Health Belief Model,
which provided an overview of participants’ perceptions and behaviours about childhood vaccinations.
Results: Vaccine associated PoM was associated with individuals’ perceptions of disease severity, with
individuals feeling more reassurance after obtaining vaccinations against diseases that they considered
to be severe compared to relatively mild diseases. Conversely, concerns about vaccination side-effects
reduced participants PoM, but the duration of this effect varied between individuals. Other factors, such
as social pressure and the emotional anxiety related to children’s feelings, or physical reactions, to vac-
cinations also negatively impacted on participants’ vaccine associated PoM.
Conclusion: Vaccine associated PoM was a consideration for some participants seeking vaccinations but
was only a minor motivating factor for these individuals. These differences stemmed from whether par-
ticipants received PoM from the uptake of a vaccination because they perceived some intrinsic benefit
from it or, conversely, they considered vaccinations as a routine health intervention. Overall, vaccine
related PoM varied between participants in magnitude and fluctuated over time, even in the same
individuals.
 2020 The Authors. Published by Elsevier Ltd. This is an open access article under theCCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
Before health care interventions are introduced in the UK, there
is often a requirement that the intervention should be cost-
effective. For vaccines, this involves measuring the net cost of a
vaccine programme, versus the health benefits gained. Current
methods for assessing the health benefit from vaccinations have
been challenged recently, as it is felt that some important benefits
are not being fully considered or missed completely [1]. Increas-
ingly evidence is showing that vaccines can have broad and endur-ing impacts on society that are not always considered in cost
effectiveness analysis [2,3]. These non-health benefits can have
various societal impacts, such as effecting educational achieve-
ment, future productivity and healthcare usage [4]. Furthermore,
it has been suggested that some members of the public might
value the ‘Peace of Mind’ (PoM) gained from knowing that they
and their family are protected from a vaccine preventable disease,
and that this PoM might be achieved not just from those who are
vaccinated, but also others in the population [5].
In recent years the UK Government has been under pressure to
address the cost-effectiveness approaches used by the Joint Com-
mittee on Vaccination and Immunisation (JCVI; the government’s
vaccine advisory committee) for assessing the benefits from child-
hood vaccinations. In April 2016 the largest health petition of its
time (signed by 823,345 members of the public) was submitted
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provision of the meningitis B (MenB) vaccine for only children aged
3–5 month, and to extend the vaccination to all children up to age
11 [6]. This petition, and the consistently high uptake rates for the
MenB vaccine [7], has been perceived as a demonstration of public
anxiety about meningitis [8]. Furthermore, in 2016 the Cost Effec-
tiveness Methodology for Immunisation Programmes and Procure-
ment (CEMIPP), an independent group set up by the government to
consider whether the method for appraising cost effectiveness of
vaccination programmes should change, recommended that non-
health benefits, such as the PoM that parents gain from getting
their children vaccinated, warranted further investigation to ascer-
tain if they should be included in future cost-effectiveness analyse
[5,9].
For PoM benefits to be considered for inclusion in decisions
regarding which vaccine programmes to fund or not, key questions
need to be answered about the nature of vaccine associated PoM
(for example, are there associations with the severity of the condi-
tion being prevented), and the duration of the experience. Previous
research has proposed that parents make decisions about
childhood vaccinations according to personal and social variables
[10–14]. Furthermore, preliminary findings from our previous
qualitative work [15] suggested that some UK members of the
public obtain PoM from vaccination and that this factor needs
more consideration. Thus, the aim of this study was to investigate
the role of PoM in influencing vaccination decisions.
1.1. Background
The Health Belief Model (HBM) is a theoretical framework that
can be used to conceptualise the attitudes and beliefs of individu-
als in an attempt to explain and predict health behaviours [16].
This psychological model has been used extensively to study vac-
cination beliefs and behaviours and in vaccination research to
identify patient perceptions of disease and vaccination [10,11,17–
21]. The HBM can be used to examine individuals’ motivations
for adopting a health-related behaviour and as such was used in
this study to understand vaccination seeking behaviours and the
role of PoM. The HBM includes six key domains which influence
health behaviours: perceived severity, perceived susceptibility,
modifying factors, perceived benefits, perceived barriers and cues
to action. Some adaptations of the model also incorporate self-
efficacy, but this was not relevant for this research.2. Methods
2.1. Study design
A focus group method was chosen, as the group dynamic cre-
ated via this approach provides rich data, especially when partici-
pants have little prior knowledge about a topic [22]. COREQ
guidelines have been used in reporting the study conduct and find-
ings [23].
2.2. Setting and participants
A qualitative convenience sampling [24] approach was used,
whereby participant selection was based on accessibility. However,
in order to increase diversity within the sample population, two
different recruitment strategies were used:
1. Previous participant group: Participants from previous qualita-
tive work about population preferences for prioritising vaccina-
tion programmes against childhood diseases were contacted via
postal invite [15].2. Parent groups (pre-school and nursery): These groups had pre-
viously participated in research based at the University of Bris-
tol and had given their written consent indicating willingness to
take part in future research.
Groups were located in North Somerset and South Gloucester-
shire. Any adult individuals (18 years) affiliated with these
groups were eligible to participate. Individuals were not excluded
due to ethnicity, gender, sexual orientation, disability or socioeco-
nomic status. Understanding how heterogeneity upon preference
for vaccines was important, therefore the role of age, gender and
parental status was investigated during analysis.
2.2.1. Data collection
Focus groups were conducted by the corresponding author G.L.
(female/PhD/senior researcher). G.L. had previously received qual-
itative training and was experienced in conducting group inter-
views with members of the public. All participants were sent
information about the study goals prior to each focus group, but
were not asked to complete any preparatory work prior to attend-
ing. Focus groups were held face-to-face, at a time and location
convenient to the majority of participants. It was emphasised at
the start of each group that participants could withdraw from
the discussion or the study at any point. Participants from each
group type (i.e. previous participant or parent group) were only eli-
gible to participate in a group with their peers. Focus groups were
facilitated by researchers from the University of Bristol (moderator
and assistant), who used a semi-structured topic guide (S1 File) to
encourage discussions on the potential social-environmental and
personal factors influencing vaccination seeking behaviour, with
particular focus on vaccine associated PoM.
Focus groups lasted one hour on average and were audio
recorded, with field notes created by the assistant. Recordings were
transcribedverbatimshortly afterwards; all datawere subsequently
pseudoanonymised. At the end of each focus group, participants
were asked to complete a demographic questionnaire; explicit writ-
ten consentwas sought prior to this data collection. The focus group
moderator (GM) explained to each participant that theywere under
no obligation to complete the questionnaire and that this had no
impacton their eligibility to contribute.All participantswereoffered
a £20 shopping voucher as reimbursement for their time.
2.2.2. Interview topic guide
A semi-structured interview topic guide (S1 File) was used to
facilitate discussions on the nature of vaccine associated PoM
and if, how and when this factor influenced individuals during
their vaccination decision making processes. The topic guide asked
participants to think about vaccination decisions they had previ-
ously made for themselves and, if appropriate, the decisions they
made for their children and whether vaccine associated PoM had
played a role.
Throughout the focus group, the interviewer was mindful that
some participants had little previous knowledge or experience of
vaccinations; this was taken into consideration by providing rele-
vant prompts to stimulate discussion. Furthermore, the inter-
viewer was mindful that both pro and anti-vaccination beliefs
were likely to be discussed, and whenever possible participants
were encouraged to discuss varying views.
2.2.3. Focus group analysis
Analysis used an inductive thematic framework approach [25].
Firstly, each transcript was read whilst listening to the focus group
audio file to help capture verbal emphases. A general coding struc-
ture was then developed and applied to large sections of text, para-
graphs and then sentences. All transcripts were reread and
compared numerous times until no new codes were found [26].
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coding process, this approach was used to detect key attributes
and identify the variety of participants’ opinions [27]. Data was
managed using NVivo software (QSR International) and analysed
concurrently, so that any future focus group discussions were used
to clarify and expand on emerging themes. The HBM was used as a
framework for presenting, conceptualising and supporting the
exploration of the qualitative results [28].
A selection of the study team coded the initial focus group tran-
script independently and then during subsequent meetings team
members developed a thematic coding scheme for all additional
transcripts [29]. Data analysis was led by G.L., with support from
an experienced research team (H.A.-J., F.C. C.T. and H.C.) with a
range of expertise; (H.A.-J.) health economist with qualitative
experience, (F.C.) health psychology with qualitative experience,
and (C.T and H.C.) epidemiologists. The breadth of experience
within the research team meant that different opinions were fre-
quently discussed during data analysis.
Ethical approval for this study was obtained in July 2017 from
the University of Bristol, Faculty of Health Sciences Research Ethics
Committee, Bristol, England (Ref: 29821).Table 1
Descriptive characteristics of focus group participants (n = 24).
Age category
Focus
group (n)
Gender (n) 18–24 years 25–34 years 35–44 years 45–54 years 55
1 (7) Female (6) 1 2 3
Male (1) 1
2 (6) Female (6) 2 1 2 1
Male (0)
3 (4) Female (3) 1 1
Male (1) 1
4 (7) Female (7) 5 1 1
Male (0)
Table 2
Additional descriptive characteristics of focus group participants (n = 24).
Ethnicity
Focus group (n) Gender (n) White
British
White
European
White and Black
Caribbean
Other
backgr
1 (7) Female (6) 6
Male (1) 1
2 (6) Female (6) 6
Male (0)
3 (4) Female (3) 3
Male (1) 1
4 (7) Female (7) 5 1 1
Male (0)
Table 3
Highest qualification of focus group participants (n = 24).
Highest qualification
Focus group (n) Gender (n) Doctorate or
equivalent
Masters or
equivalent
Bac
equ
1 (7) Female (6) 1 1
Male (1)
2 (6) Female (6) 2
Male (0)
3 (4) Female (3) 1
Male (1) 1
4 (7) Female (7) 1
Male (0)3. Results
Focus groups took place between August - September 2017.
Thirty-five individuals showed interest in participating, however
11 were not available to attend the focus groups on the scheduled
dates. In total, four focus groups were conducted; two parent
groups with seven participants, one parent group with six partici-
pants and one previous participant group with four participants
(N = 24).
Focus groups lasted between 48 and 59 min with a mean dura-
tion of 55 min. Tables 1–3 show the broad range of participants’
characteristics.
Fig. 1 shows the major findings from the thematic qualitative
analysis as a conceptual framework based on the HBM. This figure
illustrates participants’ key perceptions and behaviours relating to
vaccine associated PoM, which in turn influenced the likelihood of
accepting a vaccination.
It is worth noting, the topic guide was designed to encourage
participants to discuss the PoM associated with vaccination
decisions that they had previously made for themselves or children
in their care, however many (92%) participants were parents,Parental status
–64 years 65–74 years Not a
parent/guardian
Parent/guardian Parent/guardian
and foster carer
6
1
6
1 1 1 1
1
1 6
Religion Employment status
mixed
ound
Christian None In active
paid work
Retired Unemployed Other
1 5 4 2
1 1
5 1 5 1
2 1 1 1
1 1
4 3 2 4 1
helors or
ivalent
HND/HNC or
equivalent
A level or
equivalent
GCSE or
equivalent
None
1 3
1
1 1 2
2
3 3
Fig. 1. Factors related to vaccine associated PoM and the likelihood of accepting a vaccination.
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on childhood vaccination decisions.
3.1. Individual perception
3.1.1. Perceived severity of a disease
This element of the HBM deals with an individual’s assessment
of how severely they would be impacted if they were affected by a
health condition. Specifically, participants were asked to think
about the severity of vaccine preventable diseases and how this
impacted on their vaccination decisions. Participants from all focus
groups agreed that they felt more PoM after obtaining vaccinations
against diseases that they considered to be severe compared to rel-
atively mild diseases.
[F6] ‘‘They’re [children] probably not going to die of chicken
pox, unless it gives them a knock-on effect of something else,
are they? But there is a really strong chance that they’re going
to die of meningitis, and I think if you can vaccinate against
that, then you would. [FG1]
[F1] I think it’s the seriousness of the illness and you’d get PoM
to know you’ve protected them.” [FG1]
Nevertheless, some participants had little understanding about
the severity of vaccine preventable diseases, so felt less emotive
about the relevant vaccine.
3.1.2. Perceived susceptibility to a vaccine preventable disease
When asked to think about the likelihood of accepting a vaccine
against a preventable disease, two participants from one focusgroup discussed this as motivation for seeking a vaccination. These
participants talked about feeling more reassured after vaccinating
their children, especially if they were known to have underlying
susceptibilities to disease.
[F5] ‘‘I think if there’s a particular family history or something,
then it reassures you that if your children have that vaccination,
they’re going to be protected a little bit more than not having it.
And so, from that perspective, I can see where PoM would come
into it”. [FG1]3.1.3. Vaccine associated side-effects of the vaccine
Participants across all focus groups discussed having PoM once
they had vaccinated their child, as they felt that the vaccine would
provide protection against a specific disease. Nevertheless, this
perceived protection was often tempered with concerns about vac-
cine associated side effects.
[F4] ‘‘Once you go through the ‘light’ symptoms, let’s say, the
common ones, it’s fine. It’s like when you look at the back of
the drug and what can happen and then you start reading about
serious symptoms that could cause death or breathing prob-
lems and things like that and you start really panicking. Some-
times, I prefer not to look. That is something that can really
scare you and take away the PoM.” [FG2]
A small minority of participants were less concerned about
potential short-term side effects and took a more objective view,
believing that relatively trivial adverse reactions were preferable
to potentially contracting a vaccine preventable disease.
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injection, it’s unpleasant for them to feel a bit off colour you
know for a couple of hours or a day or so after. But that’s what
part of the vaccination is you know and again it’s okay, a bit of a
pain for them for a day. But which would you rather, you know,
that or contracting meningitis or something else. So not a big
deal for me.” [FG3]3.1.4. Vaccination perceived as routine
Some participants across three focus groups stated that they
regarded childhood vaccinations as a routine procedure and gave
them very little forethought. For these individuals there was no
indication that vaccinating their child was associated with feelings
of reassurance or PoM, rather they simply attended vaccination
clinics as directed by their healthcare providers.
[F4] ‘‘I mean everyone gets their child vaccinated. Well, not
everyone but the majority of people get their child vaccinated,
so you kind of just follow the crowd. It’s not PoM; it’s a routine.”
[FG4]3.2. Modifying factors
3.2.1. Demographic variables
Twenty-two (92%) of our participants were parents or guardians
and some of these individuals talked about the worry of being a
first-time parent and the lack of knowledge/experience about
childhood vaccinations. These individuals spoke about their tem-
porary worry, and thus reduced PoM, when taking their first child
for their vaccinations, mainly because they were unsure about
what to expect both before and after vaccination.
[F5] ‘‘The only one I was really worried about was the first injec-
tion that they get. I think it was just being a new mum and hav-
ing to take your kid for an injection. That’s the only thing that I
was really worried about. . ..you just don’t know what to expect
either, do you? You know they’re going to be in a bit of pain and
that.
[GM] So do you think that the other vaccinations that came later
were different?
[F5] No, I just knew what was coming, so I knew how to deal
with her, kind of thing.” [FG4]
Other demographics factors, such as age and gender, were
examined as possible determinants of participants opinions on
vaccine associated PoM, but no link was found.
3.2.2. Sociopsychological variables
For this study, this element of the HBM focused on the combi-
nation of social and psychological factors that influenced individu-
als’ attitudes and actions around childhood vaccinations. Most
notably, the perceived influence of healthcare providers was dis-
cussed across all focus groups, but for some this social pressure
was mitigated by the psychological concerns that they had about
their child’s wellbeing, and more specifically whether they
believed that they would be in pain or distress during a vaccina-
tion. This short-term unease was a key worry for some participants
and negatively impacted on their immediate PoM.
[F4] ‘‘So, when I was invited to go to have this vaccination for
my daughter, I was still crying and I was still upset because
you don’t want your child to be pricked in their little leg. That
was almost stopping me from going and because I was crying,
she was crying and I was thinking, ‘Oh god, she’s in pain
because of that’ but then I was thinking, ‘I will trust the profes-
sionals. This is the first child. Let’s see. I will risk it’.” [FG2]3.2.3. Structural variables
All focus groups discussed the impact of structural variables on
their PoM and resulting vaccination decisions, such as their knowl-
edge about, or more specifically lack of knowledge, about certain
vaccine preventable disease.
[F3]: ‘‘I think we’ve got so little experience of diseases that the
vaccines prevent against that you just have to guess, I guess,
because there are just not people around that get these things.”
[FG1]
Other participants talked about personal experience they
had had with certain diseases and how their perception of the
infection influenced their opinion about accepting a vaccination
against such diseases. These participants reported feeling more
PoM when vaccinating against diseases that they perceived as
common or severe.
[F6?] ‘‘I would probably consider how many times you’ve heard
of these diseases happening and how common they are because
some of it, we had diseases when we were younger, like Chicken
Pox or Rubella. There was something else, Mumps. We had
these, for example, when we were smaller and there was no
vaccination and it was okay and now they want to vaccinate
the children and then we are thinking ’Why?’ you know,
‘Why?’” [FG2]
Participants in one focus group discussed the reassurance they
received from knowing that a vaccine had been used for
many years, and although these participants did not have personal
experience to reassure them about its safety, simply knowing
that it had been used for an extended period of time gave them
PoM.
[F3] ‘‘It’s PoM associated with the vaccine having been around
for ages as well, isn’t it? You think it’s safe.” [FG1]
Conversely, participants were more cautious about vaccinations
that they considered to be ‘newer’ or vaccinations that they had lit-
tle personal experience with during their own life.
[F6] ‘‘You think, ‘Well, how much research has been done? Is
this going to be another thing where. . .?’ Especially, if it’s for
something you feel maybe they don’t really need, like the
chicken pox virus and stuff like that, you think, ‘Actually, they
might not need it, so I won’t do it’ but if you’ve already had it
yourself and you were fine, then you’re more open to letting
your children have stuff.” [FG1]
However, interestingly, this was not the case for the ‘MenB’ vac-
cine which although considered relatively ‘new’ by some partici-
pants, the perceived severity of this infection meant seeking this
vaccination provided increased PoM.
3.3. Cue to action
3.3.1. Encouragement from healthcare providers
Participants across all focus groups talked about either
receiving postal or verbal reminders offering vaccination. As dis-
cussed previously, a small minority of our participants regarded
these cues to action with some trepidation, yet most noted that
these reminders were a key motivation for attending vaccination
clinics. This factor was not found to impact on participants’ overall
PoM.
[F1] ‘‘I think that’s it though. Personally, I don’t really think
about it [vaccination]. I get told to come at that time, so I do. I
don’t really think about what it actually is or what it means.”
[FG4]
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Social media and advice from others was an issue for some par-
ticipants. These individuals mentioned the amount of conflicting
information was problematic, especially as they found it difficult
to know what sources to believe.
[F7] ‘‘I think things on the NHS website and from places of
authority and knowledge will make me feel reassured but like
the girls have said, if you see things on Facebook and social
media, it’s so conflicting. What do you believe? [FG4]
Participants also talked about the impact of the news media on
their awareness of vaccine preventable diseases and that this
was often their main source of information. The impact of the
media varied between these participants, for a small minority it
negatively impacted on their PoM and was thus a barrier to
action.
[F6] ‘‘[Y]ou probably only see it [vaccine preventable disease]
from television or media, if there are reports on countries that
don’t have the vaccinations that are so freely available to us
and then you think, ‘Oh, that’s what could happen if they wer-
en’t vaccinated’” [FG1]
All focus group participants agreed that there was more infor-
mation available now than ever before, and for some this impacted
negatively on their PoM as it complicated their vaccination
decisions.
[F4] ‘‘Maybe there is also more information now about it [child-
hood vaccinations]. Maybe people share it more, rather than
before and a few years back because I don’t remember reading
about it before. Maybe I’m more into the subject. I don’t know
but it’s definitely less PoM.” [FG2]3.3.3. Scientific research
A few participants talked about collecting information from a
range of sources to make vaccination decisions and the reassurance
they received by having access to research that were corroborated
by healthcare professionals.
[F4] ‘‘For me the PoM will be good research based on facts,
so I can make my own decision as a parent and I’m not
pushed to do things. . .. but I think that good research and pro-
fessionals backing up the idea, that would be helpful and that
would give me PoM. I will know that I’m doing the right thing.”
[FG2]3.4. Likelihood of action
3.4.1. Perceived benefits of vaccination - balance of risks
For the purposes of this study, the likelihood of action related to
whether an individual would choose to accept, or not, routine vac-
cinations offered by their healthcare provider. Some participants
described these vaccination decisions as a delicate balance
between the perceived benefits of the vaccination versus potential
risks.
[M] ‘‘I think the sort of benefits of vaccination, and vaccination
working successfully, far outweigh the risks of potential ill
effects if you like. You know it is a balancing exercise, but I think
I’d go with the group that would say ‘You know what I would
rather take the very small risk of something going awry than
taking the risk of any of my children or anyone else contracting
any of the [diseases]’. You know we’re talking about quite seri-
ous infections. So yeah, I think it’s reassurance for me and there
hasn’t been a great deal of worry that I’ve gone through, it’s a
pretty no brainer type decision I think.” [FG3]3.4.2. Perceived barrier - cost of vaccinations
Some individuals were worried about the need to pay for cer-
tain vaccinations due to age restrictions within the UK vaccination
schedule. This perceived barrier was a concern for some of our par-
ticipants with young children, as not everyone was financial able to
privately fund vaccinations, such as the MenB vaccine.
[F4] ‘‘I have friends who have children and some of them are on
low income and so they wouldn’t go through this, thinking,
‘This is too expensive’ and so they just have the basic ones.
[F2] It’s like a luxury.
[F4] Yeah, so it’s more like a luxury. But I have friends who have
money and so they will pay for extra ones. They think, ‘It’s a
PoM. Let’s do that.’” [FG2]3.5. Relative importance that participants attributed to vaccination
associated PoM
When talking to participants specifically about vaccine associ-
ated PoM, we asked them to think about the sense of wellbeing
or reassurance that they might have felt, or not, when making their
vaccination decisions. We also asked participants to talk about the
emotions they felt when making these decisions. During these dis-
cussions some participants stated that they received no PoM or
reassurance from having their children vaccinated.
[F4] ‘‘For the regular vaccinations that children get nowadays, it
was a no brainer for me personally. So, there was no feelings of
pride or joy that I allowed my child to overcome these nasty
viruses and bugs. It was just plain sailing for me because that’s
what I was going to do. [FG1]
For others, vaccine associated PoMwas important and stemmed
from the reassurance that once either they or their children had
received a vaccination, they would receive some protection from
a specific disease. This PoM was described as both temporary
and permanent, depending on the disease and vaccination.
[F1] ‘‘Well, just like with the flu jab. For me, once they’d had it
and they were okay for the next couple of weeks, then I felt
reassured that they won’t get flu for the year.” [FG1]
[F5] ‘‘I think it gives you PoM that whatever the vaccine is
you’ve just had done, obviously you want it done for a reason,
and so it just gives you PoM for that reason at that particular
time. Like people are saying, it’s one less thing to worry about;
a little bit of worrying, but not as much as if they had have had
it. It’s just PoM really. You’re calmer [laughter].” [FG1]3.5.1. Difference in PoM between vaccinating yourself versus your
child
Some participants talked about being parents and the pressure
they felt to make vaccination decisions that were in their child’s
best interests, especially since their children were too young to
decide for themselves.
[F2] ‘‘It’s about the vaccination isn’t it, it’s about the protection
that that vaccination will give you and what side effects they
are. If you know what side effects they are, as you were saying,
you can be vigilant. You know your child, you know what’s nor-
mal for them and what’s not. So, you are alert and aware and
you can act as soon as possible. So, it’s very emotive all the
way through you know, all through their childhood isn’t it
you know. . .you want them to be in the best of health, so any-
thing that you do is all in their best interest, you know, whether
that’s education or health you know, but you are making that
decision, the needle’s not going into you, it’s going into some-
body else.” [FG3]
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would feel if they were responsible for making the wrong vaccina-
tion decisions.
[F5] ‘‘No, if there was a repercussion for your child and the
repercussion was because you decided, ‘Well actually, I’m not
going to give the chicken pox vaccination’ and they get chicken
pox, then you feel guilty. They’re your offspring. That’s, they’re
part of you and all you want to do is protect them the best you
can and to the best of your ability. When something goes
wrong, every parent, no matter the slightest little thing, you feel
guilty.” [FG1]4. Discussion
4.1. Principal findings
The finding presented in this paper, using the Health Belief
Model, indicates that there was a difference in individuals’ vaccina-
tion associated PoM depending on their perceptions, concerns, and
motivations associated with vaccination seeking behaviours. Vac-
cination associated PoM was mainly found to originate from the
perceived benefits of having a vaccination and reassurance derived
from the belief that once vaccinated an individual would receive
some level of protection against a certain disease. Nevertheless,
this reassurance was sometimes diminished by sociopsychological
concerns, such as social media stories about potential vaccination
side effects and concerns about the short-term pain their children
might suffer during vaccination. As an overall concept, vaccine
associated PoM was important to some participants, but was not
a consideration for other. These differences largely stemmed from
whether individuals received wellbeing from their child having a
vaccination because they perceived some intrinsic benefits or, con-
versely, they considered vaccinations as a routine health interven-
tion. Overall, participants demonstrated that vaccine associated
PoM fluctuated in both magnitude and duration, and occurred at
different points on their vaccination timeline. These findings indi-
cate that PoM should be considered in the current health economic
framework used by decision makers, however, further work is
required to further define and quantify PoM for use in such
analyses.
4.1.1. Relevance to other work
Although various studies have considered and presented factors
influencing vaccination decisions, some even using the HBM
framework, to the authors’ knowledge this is the first study to view
decision making for childhood vaccinations through the lens of
PoM [17,30–32]. A similar concept of parental ‘anticipated regrets’
related to vaccinations was previously suggested by Sadique et al.
(2013), an idea that seems similar to the PoM attribute investi-
gated in this study [33]. These anticipated regrets were explained
as parents making a vaccination decision by balancing the per-
ceived risks associated with vaccine associated side-effects in
instances when a vaccination was taken, compared to potentially
suffering from a vaccine preventable disease when a vaccination
was not taken. This approach was similar to those discussed by
participants in our previous study [15].
Similarly, Gallagher and Poverty (2006) explored the effect of
anticipate regret on the intention of older adults to vaccinate
against influenza and found that anticipated regrets significantly
influenced respondents’ attentions to vaccinate[34]. Nevertheless,
there remains the issue of how to define the somewhat intangible
concept of PoM (or anticipated regrets) in such a way that it can be
assessed and incorporated into cost-effectiveness assessments. A
review by Herdman et al (2016) highlighted the need for more
studies to elicit utility weights for paediatric vaccines againstinfectious disease, arguing that there are aspects specific to vacci-
nes that should be taken into consideration when making cost-
effectiveness decisions [35]. Clearly future research on this topic
is warranted.
4.1.2. Strengths and limitations
The strengths of our study included using a qualitative method
appropriate to the research question. Focus groups were used
because they generate rich data about personal attitudes and
beliefs, whilst the HBM was valuable for providing insight on the
attitudes and beliefs of participants in order to explain their health
behaviours [16,36]. A constant comparison approach allowed us to
explore themes as they emerged from the data [37]. Reliability was
aided by analysing the full transcripts using qualitative software
and reaching a coding consensus with all co-authors. While our
sample was relatively small, we achieved data saturation.
One of the limitations of this study the use of a convenience
sampling approach; therefore, selection bias is a concern [24]. It
is possible that those who participated had different views about
vaccination associated PoM than those who did not participate.
Nevertheless, those individuals who participated in the study were
overall demographically heterogeneous, except in terms of gender
and parental status. The overrepresentation of women in research
about childhood vaccination is common, and reflects the fact that
mothers are more commonly identified as the primary healthcare
decision-maker for their children [38]. The authors would recom-
mend conducting additional research with diverse groups in order
to further explore this topic.
Some of the focus groups involved ’natural’ groups, where the
participants already knew each other or the researchers. An advan-
tage of using natural groups is that participants feel more comfort-
able and are more likely to speak freely than if they were amongst
strangers. Contrariwise, there may also be a disadvantage in that
participants follow established social norms and are thus less likely
to discuss opposing views [36,39]. From an observational perspec-
tive, the natural group sessions did not appear different from the
other focus groups in terms of participant interactions or opinions
expressed, but there may have been unobserved influences.
4.1.3. Reflexivity
Throughout the study process, the authors were aware of our
own positions and reflected on how these could influence the
study design, conduct and analysis. Two authors work to inform
the Joint Committee on Vaccination and Immunisation (indepen-
dent expert advisory committee of the United Kingdom Depart-
ment of Health) and as such could be considered advocates for
childhood vaccination. Thus, it is possible that these biases may
have influenced the manner in which the data was interpreted or
the implications for future research and practice that have been
drawn.5. Conclusions
This study explored the perceptions of the general public on
vaccine associated PoM. Using the HBM to present, conceptualise
and explore our focus group date, several themes were identified
as important. Our participants noted that making vaccination deci-
sions was a difficult process and required striking a delicate bal-
ance between the perceived benefits versus potential risks of
each vaccination. For some, the magnitude of PoM was dependent
on their perceptions of disease severity and perceived susceptibil-
ity to disease. Furthermore, opinions of vaccine associated side-
effects were also found to reduce PoM, but the duration of this
effect varied between individuals. Sociopsychological modifying
factors also impacted on participants’ PoM, including social pres-
G. Lasseter et al. / Vaccine 38 (2020) 2424–2432 2431sure and the emotional anxiety related to children’s reactions to
vaccinations. Overall, vaccine associated PoM was found to vary
in duration, with participant reporting it as both a short-term
and long-term consideration, with the time of occurrence, duration
and magnitude influenced by an individual’s attitudes and beliefs
towards a vaccine and/or the related preventable disease. Whilst
recognising that the focus group participants were not generalis-
able, these findings provide evidence that PoM is a key attribute
of some individual’s vaccination decision-making process, and
has some value to the recipients, therefore there may be a case
for creating a framework for quantifying such benefits in the
cost-effectiveness evaluation of vaccines, which in turn could have
significant policy implications.
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